FDA Investigator Irina Gaberman
Irina Gaberman has inspections in 11 countries as of 14 Dec 2023. Irina Gaberman has collaborated with a combined 3364 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
311
Last Inspection Date:
14 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Peru,
Israel,
Chile,
Philippines,
Poland,
United Kingdom of Great Britain and Northern Ireland,
Germany,
Japan,
Belgium
Co-Investigator(s):
Alia Legaux,
Alice S Tsao,
Amber D Brodas,
Amy Constantine,
Amy Kim,
Amy W Yan Mai,
Andrew F Cohen,
Angela E Glenn,
Angela Jourdain,
Ann M Stewart,
Annette Melendez,
Anthony N Onianwa,
Armando Chavez, MS,
Ashley Polizzotto,
Barbara Paul,
Benton M Ketron,
Bijoy Panicker,
Bradley Dworak, PhD,
Brandon L Mariner,
Brandy N Lepage,
Brentley S Collins,
Bryce A May,
Burnell M Henry,
Byungja E Marciante,
Carl A Huffman, III,
Carl E Lovrich,
Carolyn J Cook,
Catherine M Beer,
Charanjeet Jassal,
Charisse K Green,
Christian D Lynch (CDL),
Christian Parra,
Christopher J Adams,
Cody D Rickman,
Cordelia J Brammer,
Courtney N Long,
Cynthia Jim, CSO,
Dave M Deroche,
David Galler Veety,
David R Delucia,
Deborah M Trout,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Denise L Terzian,
Diana M Rand,
Dipesh K Shah,
Douglas G Ng,
Dr. Barbara D Paul, PhD,
Dr. Gang Wang, PhD,
Dr. Robert C Horan, MD,
Emily A Walters,
Eric J Reisenauer,
Eric Rothschild,
Evelyn Taba,
Evelyn Taha,
Fatima Bassa,
Frank Verni,
Garrad R Poole,
Gary J Lader,
Gary J Lehr,
Gayle J Gehrman,
Gene D Arcy,
George C Amedro,
Gloria E Parra,
Gloria Parra,
Gray,
Harry J Brewer,
Haydee B Romero,
Hoimay Chan,
Holly Brevig,
Huascar Batista,
Iram R Hassan, PhD,
Jackson Y See,
Jacqueline Mdiaz Albertini,
James A Liubicich,
Jane Chen,
Jason Kwong,
Jay T Wong,
Jeanette L Mcginnis,
Jeanne J Chiu,
Jeanne J Thai,
Jennifer A Bazergui,
Jennifer L Custodio,
Jennifer Macmillan,
Jessica M Monteiro,
Joan Johnson,
Joanne M Schlossin,
John E Aghadia,
Jose O Hernandez,
Joseph Maselli,
Joy P Matthias,
Juan Rjimenez Garcia,
Juanita P Versace,
Juliana Falla,
Ka L Wong,
Karan L Blum,
Karen L Kosar,
Kathleen B Swat,
Kellie Leveille,
Kenneth S Boehnen,
Kerry D Noto,
Kerun Hardeo,
Kevin A Gonzalez,
Kimberley A Ricketts,
Kimberly Y Smithson,
Kwong P Lee,
L Gnnmassimia Massimilla, PharmD,
Lara Schankweiler,
Laura E Garcia,
Laura M Howard,
Laura Schankweiler,
Lauren E Blaser,
Laurie A Haxel,
Laurissa S Flowers,
Leena Thomas,
Leeterry Moore,
Linda M Sacco,
Linda Thai,
Lisa Mathew,
LTJG Matthew R Palo,
Lu Deng,
Malgorzata G Norton,
Manhar R Patel,
Marcia A Worley,
Marianna Viner,
Marla A Cassidy,
Marlene L Davis,
Mary Ewilkerson Brinsko,
Mary T Carden,
Matthew A Spataro,
Matthew B Casale,
Mercedes G Castillo,
Mercy O Quagraine,
Meredith P Soehl, Investigator,
Michael G Sinkevich,
Michael Levin,
Mindy M Chou,
Mohammad Heidaran, PhD,
Monika Borkowska,
Morgan J Matthews,
Mpris Inspector,
Nancy L Neiger,
Neil J Bonzagni, PhD MPH,
Nicholas M Smith,
Olga Simakova,
Omadevi Somai, Investigator,
Pankaj H Amin,
Patricia A Clark,
Paul Mouris,
Perez,
Peter Abel,
Peter M Trunk,
Peter R Caparelli,
Prabhu P Raju,
Randolph Campos Santiago,
Randy D Baxter,
Robert C Howard,
Robert C Steyert,
Samina S Khan,
Samuel T Walker,
Sarah A Meehan,
Sarah B Tanksley,
Shari L Kahn,
Shreya Shah,
Simone E Pitts,
Sonia E Ortiz,
Stanley Noneze,
State Agency,
Stephanie T Durso,
Steven M Weinman,
Susan M Jackson,
Susan W Ting,
Thai D Truong,
Thomas P Hansen,
Timothy M Martin,
Tonia L Sawyer,
Tracy M Portelli,
Uttaniti Limchumroon (Tom),
Valerie A Potopsingh,
Valerie C Reed,
Valerie Grecek Trinh,
Valerie J Grecek Trinh,
Valerie Trinh,
Vanessa R Muller,
Vioela J Caze,
Vivian Garcia,
Wayne W Grundstrom,
Wendy M Stone,
William C Lubas,
Willy A Orantes,
Xiaokuang Lai, PhD,
Yong Hu,
Yonggang Wang, PhD,
Yvonne M Santiago,
Zameer Farouk
Irina Gaberman's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more